KAYLIE FRANKLIN: Open Payments
NPI 1093024853 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 23 payments from 9 companies in 2025. Trend: 2023 $706 · 2024 $340 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $105 |
| Exeltis, USA Inc. | 3 | $67 |
| Sage Therapeutics, LLC | 3 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $44 |
| Hologic Sales and Service, LLC | 2 | $32 |
| MILLICENT US INC | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Provepharm Inc. | 1 | $17 |
| Ethicon US, LLC | 1 | $14 |
Products named: GEMTESA, SLYND, ZURZUVAE, FEMLYV, Qelbree, MYFEMBREE, BLUDIGO, MYOSURE TISSUE REMOVAL DEVICE.
Industry payments across AL — which companies pay providers there.
